Anticoagulants Market Report by Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low Molecular Weight Heparin (LMWH), Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant, Injectable Anticoagulant), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, and Others), Application (Atrial Fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others), and Region 2024-2032

Anticoagulants Market Report by Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low Molecular Weight Heparin (LMWH), Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant, Injectable Anticoagulant), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, and Others), Application (Atrial Fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A4360
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Anticoagulants Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Novel Oral Anticoagulants (NOACs)
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Heparin and Low Molecular Weight Heparin (LMWH)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Vitamin K Antagonist
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Route of Administration
    7.1    Oral Anticoagulant
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Injectable Anticoagulant
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Stores
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Application
    9.1    Atrial Fibrillation and Heart Attack
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Stroke
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Deep Vein Thrombosis (DVT)
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Pulmonary Embolism (PE)
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10   Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Alexion Pharmaceuticals Inc
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Aspen Holdings
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Bayer AG
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Boehringer Ingelheim International GmbH
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    Bristol-Myers Squibb Company
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Daiichi Sankyo Company Limited
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Dr. Reddy’s Laboratories Ltd
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    GlaxoSmithKline plc
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Johnson & Johnson Private Limited
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Pfizer Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Sanofi
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
Figure 2: Global: Anticoagulants Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2023
Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2023
Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2023
Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Anticoagulants (Pulmonary Embolism-PE) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Anticoagulants (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: North America: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: United States: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Canada: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: China: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Japan: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: India: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Australia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Europe: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Germany: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: France: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Italy: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Spain: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Russia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2023
Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Global: Anticoagulants Industry: SWOT Analysis
Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Anticoagulants Market: Competitive Structure
Table 8: Global: Anticoagulants Market: Key Players

Anticoagulants Market Report by Drug Class (Novel Oral Anticoagulants (NOACs), Heparin and Low Molecular Weight Heparin (LMWH), Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant, Injectable Anticoagulant), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, and Others), Application (Atrial Fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More